**Baseline Monitoring**

- Complete blood count and hemogram

- Erythrocyte sedimentation rate or C-reactive protein

- Liver function test

- Renal function test and urinalysis

- Serum electrolytes

- Anti-nuclear and anti-dsDNA antibodies

- Screening for hepatitis and HIV infection

- Chest X-ray

- Tuberculin skin testing or interferon-gamma release assay test

- Pregnancy test in females of childbearing age

- If indicated – serology for varicella zoster and measles.

**Ongoing Monitoring**

- Evaluation of response to treatment can is measurable by respective assessment scores, i.e., Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index (DLQI), PCDAI, PUCAI at three months initially and subsequently every six months.

- Complete blood count and hemogram repeated at three months and every six monthly thereafter

- Liver function test, Renal function test, serum electrolytes, and urinalysis undergo evaluation at three months and every six months.